• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP Back to Search Results
Device Problem Leak/Splash (1354)
Patient Problem No Code Available (3191)
Event Date 01/01/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).Since the actual date of the incident is not available the year ((b)(6) 2016) when the patient was treated with the medical device was used as an estimated date of the incident.
 
Event Description
Within the article ¿endovascular repair of 40 visceral artery aneurysms and pseudoaneurysms with the viabahn stent-graft: technical aspects, clinical outcome and mid-term patency¿, published by massimo venturini et al, within the cardiovascular and interventional radiological society of europe (cirse) 2017, clinical investigation abstract, accepted on november 13, 2017, the published results indicated the following: the purpose of this single-center study was to retrospectively report a 14-year experience with the peripheral, self-expandable viabahn stent-graft in the endovascular repair of 40 visceral artery aneurysms (vaa) and visceral artery pseudoaneurysms (vapa).As primary outcomes, peri-procedural complications, technical success 30-day clinical success, re-interventions and 30-day mortality were assessed.As secondary outcomes, stent-graft patency and persistent aneurysm devascularization at mid- (6¿12 months) and long-term (more than 12 months) were assessed.Patient (b)(6) ((b)(6)) presented with a vapa within the superior mesenteric artery proximal, which was treated with one gore® viabahn® endoprosthesis (8mm x 2,5cm), where the approach was gained through the right axillary, in an emergency procedure 2016.The article stated that this case required a complex vascular reconstruction of the superior mesenteric artery after pancreatic surgery, with persistent bleeding after implantation of the gore® viabahn® endoprosthesis and that the patient was re-submitted to surgery.Within the first 30 days the patient died due to a hemorrhagic shock.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
barbara ulrich
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key7129066
MDR Text Key95229311
Report Number2017233-2017-00662
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P130006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,litera
Reporter Occupation Physician
Type of Report Initial
Report Date 11/29/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/19/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age66 YR
-
-